Q301--Transplant Rejection Detection Molecular Genetic Testing

VETERANS AFFAIRS, DEPARTMENT OF

Notice type
Sources Sought
Solicitation #
36C25926Q0543
NAICS
621511
PSC
Q301
Posted
June 10, 2026
Response due
June 30, 2026
Place of performance
Salt Lake City

What this opportunity is

The Department of Veterans Affairs is seeking sources for Transplant Rejection Detection Molecular Genetic Testing, specifically for the Salt Lake City VA Medical Center. This opportunity falls under NAICS 621511 and is categorized as a Sources Sought notice, indicating it is for market research rather than a solicitation. Small businesses with capabilities in molecular genetic testing, particularly those offering services related to transplant assessment and kidney disease, may find this opportunity relevant. Interested contractors should prepare to submit their qualifications and proposed solutions, as responses will inform the government's planning but will not lead to an immediate contract award.

Analysis by Mindy, grounded in the SAM.gov notice.

Description

DEPARTMENT OF VETERANS AFFAIRS VA MEDICAL CENTER, SALT LAKE CITY, UT STATEMENT OF WORK Transplant Rejection Detection Molecular Genetic Testing Introduction Department of Veterans Affairs, Veterans Health Administration, Salt Lake City VA Medical Center (VAMCSLC), 500 Foothill Drive, Salt Lake City, Utah 84148 has a requirement for molecular genetic testing for transplant rejection. The contract will be awarded as a firm fixed price contract for one base period with four optional renewal periods. Scope of Work The Contractor will provide diagnostic laboratory services that monitors transplant patients and enables a timely detection of organ rejection to improve patient outcome, through molecular expression genetic blood testing, which will detect organ rejection, guide treatment and support patient care. Description The contractor shall be responsible for performing laboratory testing, analysis, and result interpretation on behalf of the VAMSLC facility in accordance with the terms, conditions, and provisions outlined thereof. These services shall include the performance of molecular analytical testing as defined by the contractors reference test manual, the reporting of molecular analytical test results, and consultative services as required to assimilate the full scope for patient care. The services performance shall include specialized molecular analytical testing with varying levels of support services depending on the unique characteristics presented by each individual ordering activity. The contractor shall perform testing entirely upon their premises. Tests will be performed and reported within established vendor turnaround times. The contractor shall carry out its functions hereunder in full compliance with all local, state, and federal laws or regulations as they pertain to a licensed clinical laboratory. The contractor shall provide individual patient-chartable test result reports meeting Clinical Laboratory Improvement Amendments (CLIA) requirements. The contractor shall provide all appropriate requisition forms and unique supplies needed for specialized collection of samples, at no additional charge. Notwithstanding, anything to the contrary in this Agreement or otherwise,The contractor shall not release patient records that include test results, without the specific written consent to release such information as provided by the patient, to any person other than the ordering healthcare provider or designee. All patient records shall be treated as confidential so as to comply with all state and federal laws regarding the confidentiality of patient's records. This provision shall survive termination of this Agreement. The required highly specific molecular testing reference laboratory services include but are not limited to the identified required test menu testing, specimen preparation and storage of clinical laboratory specimens, performance of analytical testing; reporting of analytical test results; and consultative services. Schedule of Services Description/Part Number Molecular expression transplant assessment testing Molecular Assessment for Kidney Disease Molecular Genetic Prenatal Screening Test General Requirements The contractors standard price list of all testing services available along with the price to be billed to the VHA for each testing service shall reflect that which is listed in their GSA price list. The price list, at a minimum, shall include the following data elements: CPT code Product Name/Description Price Test description, including reference ranges and units of measurement Maximum turn-around-time (TAT) shall not exceed three weeks from specimen submission.   Test Result Reporting The Contractor shall provide encrypted and/or secured electronic transmission (i.e., fax and/or on-line web access) of all completed and/or partial test results to the ordering activity within published turnaround time (TAT), except where specified. (See 5.2. of Contractor’s Responsibilities). Mandatory Requirements Licensing and Accreditation: Only fully licensed and accredited laboratories actively engaged in providing the specific services and laboratory testing outlined. The contractor shall have all licenses, permits, accreditation and certificates required by law. The reference laboratory must be licensed and accredited by the College of American Pathologists (CAP) and/or other state regulatory agencies as mandated by federal and state statutes. In addition, the laboratory must be certified as meeting the requirements of the Department of Health and Human Services Clinical Laboratory Improvement Amendments of 1988. The contractor shall provide a copy of all relevant permits/licenses and certifications inclusive of any sanctions current or pending throughout the United States of America prior to contract award. In addition, the contractor shall be responsible for providing a written guarantee or evidence that all subcontractors have appropriate licensure and accreditation to perform tests that the primary contractor cannot perform prior to contract award. Any proposed subcontractor changes during the contract performance period must have prior approval by the Contracting Officer (CO). The Contractor policies and procedures shall comply with Health Insurance Portability and Accountability Act (HIPAA). The contractor will provide and maintain quality assurance programs which meet federal regulations for laboratory operations. The contractor will be certified by the College of American Pathologist under the CLIA. The contractor shall notify the contracting officer in writing of any malpractice investigation or licensure or certification suspension which concerns the contractor or any employees, within 24 hours of notification of an investigation or suspension. Contractor Personnel: The contractor shall maintain current accreditation and notify the Contracting Officer of any lapse in state license, CLIA

Source: SAM.gov, as posted. Verify the current solicitation before responding.

Pursue this opportunity with Mindy

See who holds it now, who else is bidding, and draft your response — grounded in real government data, not generic AI.

View the original notice on SAM.gov ↗

Similar Active Opportunities (NAICS 621511)